(Press-News.org) Researchers from Ludwig-Maximilians-Universität (LMU) in Munich have identified an enzyme that is involved in a modification pathway that is essential for bacterial pathogenicity. Because it shows no similarity to other known proteins, it may be an ideal target for development of novel antimicrobial drugs.
Studies on a number of pathogenic bacteria have shown that these strains become pathogenic only when an enzyme called elongation factor P (EF-P) is chemically modified on a conserved lysine residue. EF-P is a universally conserved translation factor, which is involved in protein synthesis. Two enzymes are known to be involved in modifying the conserved lysine of EF-P, however these enzymes cannot fully account for the pattern of modification seen on EF-P in living cells.
The mystery molecule
Thus, at least one other protein must be involved in the modification process – however to date it has proved to be particularly elusive. Now a research team led by LMU biochemist Daniel Wilson, who is also affiliated with the Center for Integrated Protein Science Munich (CIPSM), a Cluster of Excellence at LMU, has succeeded in identifying the mystery protein as the enzyme YfcM and showing that it displays hydroxylase activity. Strikingly, YfcM shows no sequence similarity to any other known protein and therefore may have a unique structure.
This is not the only reason why discovery of YfcM will arouse great interest. "YfcM may turn out to be an ideal target for the development of new - and urgently needed – antibiotics, however more insight will be needed to ascertain the role of the YfcM mediated hydroxylation of EF-P," says Wilson.
### END
Infection biology: The elusive third factor
2012-06-22
ELSE PRESS RELEASES FROM THIS DATE:
Earth observation for us and our planet
2012-06-22
The Rio+20 summit on promoting jobs, clean energy and a more sustainable use of our planet's resources closed today after three days of talks. During the summit, the role of Earth observation in sustainable development was highlighted.
In 1992, a blueprint to rethink economic growth, advance social equity and ensure environmental protection was adopted at the Earth Summit in Rio de Janeiro, Brazil.
Now, 20 years later, the Rio+20 Summit brought participants from governments, the private sector, non-govermental organisations and other stakeholders once again to Brazil ...
New technique allows simulation of noncrystalline materials
2012-06-22
CAMBRIDGE, Mass. -- A multidisciplinary team of researchers at MIT and in Spain has found a new mathematical approach to simulating the electronic behavior of noncrystalline materials, which may eventually play an important part in new devices including solar cells, organic LED lights and printable, flexible electronic circuits.
The new method uses a mathematical technique that has not previously been applied in physics or chemistry. Even though the method uses approximations rather than exact solutions, the resulting predictions turn out to match the actual electronic ...
Win GBP500 to Spend at Next in a Mummy Stylist Blogger Competition
2012-06-22
Whether you're a mummy-to-be who is loving the latest maternity dresses, or a proud mum who likes to style up the little ones, simply style an outfit from this season's Next's maternity or childrenswear ranges - to value of GBP500 and write an accompanying blog post telling Next why these are your fashion favourites.
The Next's Mummy Stylist competition allows you to show off your creative flair with moodboards, links, pictures and social platforms to tell everyone about why your style choices shine above the rest. Be as original and imaginative as you like; perhaps ...
Prompt Proofing Blog Post: Book Review: Life of Pi by Yann Martel
2012-06-22
First published over 10 years ago, this novel was widely acclaimed and won the Man Booker Prize for Fiction in 2002. On the surface it is a fantasy adventure tale of a young man surviving more than seven months adrift in the Pacific, in the company of a 450-pound Bengal tiger.
To be fair, I should confess that I am not generally a big fan of 'castaway' novels; despite this, I found Life of Pi so intriguing that I read it one sitting, even though I was guilty of skimming a little over some of Pi's adventures while adrift in the ocean. Without wishing to give away too ...
Bce-online.com Says in the World of Business Nothing is More Ubiquitous Than the Business Card
2012-06-22
A business card is tangible, something that can be handled and felt, which in this day and age of 'virtual' everything is something that people like. A great business card can make a lasting impression, especially if it's visually striking or unique in some way. In fact, a well-designed business card that uses high-quality materials can be as good at making sales as any brochure or sales pitch, and sometimes better.
Bce-online.com is a high-quality printing service that specializes in business cards that are unique, high quality and a cut above the rest. They use the ...
Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
2012-06-19
Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow.
One of the difficulties doctors face in treating MM comes from the fact that cancer cells of this type start to develop resistance to the leading chemotherapeutic treatment, doxorubicin, when they adhere to tissue in bone marrow.
"The nanoparticles we have designed accomplish many things at once," says Başar Bilgiçer, assistant professor of chemical and biomolecular ...
U of M researchers find natural antioxidant can protect against cardiovascular disease
2012-06-19
MINNEAPOLIS/ST. PAUL (06/15/2012) – University of Minnesota Medical School researchers have collaborated with the School of Public Health and discovered an enzyme that, when found at high levels and alongside low levels of HDL (good cholesterol), can dramatically reduce the risk of cardiovascular disease.
The enzyme – glutathione peroxidase, or GPx3 – is a natural antioxidant that helps protect organisms from oxidant injury and helps the body naturally repair itself. Researchers have found that patients with high levels of good cholesterol, the GPx3 enzyme does not make ...
Ionic liquid improves speed and efficiency of hydrogen-producing catalyst
2012-06-19
RICHLAND, Wash. -- The design of a nature-inspired material that can make energy-storing hydrogen gas has gone holistic. Usually, tweaking the design of this particular catalyst -- a work in progress for cheaper, better fuel cells -- results in either faster or more energy efficient production but not both. Now, researchers have found a condition that creates hydrogen faster without a loss in efficiency.
And, holistically, it requires the entire system -- the hydrogen-producing catalyst and the liquid environment in which it works -- to overcome the speed-efficiency ...
Chemotherapy effective for patients with resected SCLC or large-cell neuroendocrine carcinoma
2012-06-19
DENVER – Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were treated with perioperative chemotherapy and surgery had better overall survival outcomes than patients treated with surgery alone.
Small-cell lung cancer (SCLC) represents about 15 percent of lung cancers annually. Of those, about 30 percent of patients have limited disease SCLC. Whereas large-cell ...
Quality of life study shows stereotactic ablative radiotherapy effective treatment; stage I NSCLC
2012-06-19
DENVER – Until recently, many elderly patients with stage I non-small cell lung cancer were left untreated because treatment may not improve their quality of life. However, stereotactic ablative radiotherapy (SABR) has become one of the standards of treatment for these patients. The outpatient treatment given over a two-week period allows frail patients to undergo the treatment.
Researchers wanted to know if this treatment maintained the same health-related qualify of life levels as patients receiving surgery. The researchers received questionnaires from 382 patients ...